Skip to main content
Premium Trial:

Request an Annual Quote

Sage Bionetworks to be NCI Center

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Seattle's Sage Bionetworks, a non-profit medical research organization, will use a grant of $6.7 million from the National Cancer Institute to establish a new interdisciplinary research and training center, Sage said today.

Funded under the NCI's Integrative Cancer Biology Program (ICBP) the center will conduct genomics and other biomedical research, and will support training of four postdoctoral researchers each year.

Sage also will collaborate with the Fred Hutchinson Cancer Research Center, The Johns Hopkins University, The Dana Farber Cancer Institute, The University of Hong Kong, the Netherlands Cancer Institute, and other ICBP Centers.

Sage Bionetworks President Stephen Friend said in a statement that the grant "is a wonderful endorsement for our young organization and validates our vision to establish a contractor-based integrative genomics and network biology resource to accelerate drug development."

The research projects initially will focus on breast, colon, liver, and pancreatic cancer, and the computational models developed will be validated in the laboratory to test their accuracy and refine their models.

"Sage was established based on three themes; biomedical research, integrative genomics platform building and training," Jonathan Derry, Sage's research director, added. "This new NCI Center represents the first component of our training mission."

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.